Executive Search Success Story: Building a Regulatory Affairs Team for a Combination Products Company

How JRG Partners executed a confidential, multi-role regulatory affairs retained search strategy that equipped a fast-growing life sciences company with the critical global strategy, drug-device integration, and compliance leadership required to seamlessly unify disparate regulatory pathways and support multiple late-stage clinical programs.

The Challenge

A fast-growing life sciences company specializing in combination products was advancing multiple late-stage clinical programs. To support its aggressive clinical timeline and secure international market approvals, the enterprise needed to overhaul its regulatory oversight structure and unify separate technical pathways. Leadership identified several critical regulatory and market pressures:

• Navigating highly complex, evolving FDA, EMA, and global combination product regulations
• Integrating distinct drug and device regulatory pathways under a singular, unified strategy
• Supporting multiple high-stakes, late-stage clinical programs simultaneously
• Expanding market footprints into new international jurisdictions with differing regulatory frameworks
• Strengthening internal quality architectures and compliance verification systems
• Building long-term regulatory leadership depth and eliminating succession risks

The enterprise determined that stabilizing its multi-site clinical operations required a synchronized corporate management structure spanning the VP Regulatory Affairs, Head of Global Regulatory Strategy, Director of Regulatory Affairs, Regulatory Affairs Lead for Drug-Device Integration, Chief Quality & Compliance Officer, senior regulatory affairs managers, and clinical-regulatory interface leaders. Successfully executing this multi-role mandate required an executive search partner combining technical vertical literacy in combination products with a direct line to a global pool of passive life sciences talent. For organizations assessing how distinct medical device platforms scale post-market compliance architectures outside of therapeutic drug-device integration lines, a parallel analysis can be reviewed in Medical_Device_Software_Engineering_C_Whitelabeled.docx.

Why They Chose JRG Partners

Deep Combination Product Regulatory Specialization

Unlike generalist recruiting agencies that lack functional immersion in intersecting biological and mechanical frameworks, JRG Partners maintains dedicated practices spanning combination product regulatory affairs, drug-device integration, and global submission strategy. Our consultants carry a detailed operational understanding of multi-jurisdictional lifecycles and the specialized governance standards required to support continuous product innovation.

Real Access to Passive Talent

The most capable global regulatory strategists and compliance executives are typically fully integrated into high-performing corporate systems, meaning they rarely monitor traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, proprietary market intelligence, and executive networks to directly engage high-performing passive leaders invisible to standard sourcing methods.

Confidential Search Execution

Because this leadership architecture was built during a critical expansion phase where multi-region submissions and active clinical pipelines were at stake, absolute discretion was mandatory. JRG Partners deployed a highly secure, confidential vetting and outreach framework that successfully insulated the client’s strategic positioning, protected commercial IP, and maintained total candidate trust throughout the lifecycle.

Global Sourcing Reach

Sourcing specialized regulatory executives capable of navigating contrasting global frameworks required an outreach strategy unconstrained by regional boundaries. JRG Partners executed a coordinated talent acquisition strategy across primary pharmaceutical, medical device, and combination product hubs spanning North America, Europe, and Asia, providing corporate sponsors with an elite shortlist of proven, cross-border lateral talent.

Our Corporate Search Strategy

Phase 1 — Strategic Alignment & Leadership Assessment

Our consultants partnered directly with the board and executive team to map existing structural gaps, identify hidden succession risks, clarify filing milestones, and define the exact leadership competencies required for long-term clinical integration. Rather than matching candidates against legacy job descriptions, we built forward-looking executive profiles dynamically tied to the enterprise’s long-term commercialization strategy.

Phase 2 — Multi-Sector Market Mapping

JRG Partners executed an exhaustive market-mapping initiative targeting process-driven life sciences, biotech, and pharmaceutical environments globally. Our comprehensive market map targeted key talent pools across pharmaceutical companies, medical device manufacturers, biotech organizations, combination product developers, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs).

Phase 3 — Targeted Executive Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated high-achieving corporate leaders with verified records of success in drug-device integration. Only candidates demonstrating clear, measurable operational impact and rigorous submission fluency advanced to the final evaluation round.

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials. Our consultants conversion-tested strategic and functional capabilities, global submission agility, team-building and leadership philosophies, cross-functional communication skills, and long-term retention potential.

Key Outcomes

• 300+ senior corporate regulatory affairs, compliance, and drug-device integration executive profiles systematically mapped across major North American, European, and Asian life sciences hubs.
• Successfully placed and integrated a complete global regulatory leadership framework—spanning the Chief Quality Officer, vice presidents, and global strategists—through a targeted retained search.
• Unified separate drug and device filing structures under a single, cohesive clinical strategy by installing process-driven regulatory interface executives.
• Accelerated international market validation and standardized product lifecycles by placing forward-thinking drug-device integration leads and program directors.
• Mitigated long-term operational risks and optimized submission cycle times by placing specialized, data-driven regulatory affairs leaders.
• Protected crucial filing data, sensitive clinical protocols, and corporate expansion metrics during high-stakes transition phases through strict search confidentiality.
• Provided the Board of Directors and CEO with a high-performance management framework explicitly equipped to eliminate compliance gaps and drive profitable technical innovation at scale.